Type 1 diabetes immunotherapy: is the glass half empty or half full?
Where this comes from
- Record sourced from PubMed, PMID 21832236.
- Also identified by DOI 10.1126/scitranslmed.3002981.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reevaluation of clinical data from the recent failed immunotherapy trials suggests that researchers should continue the quest to cure type 1 diabetes with immune therapies.
Medical subject headings
- Diabetes Mellitus, Type 1
- Immunotherapy